A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study published in Lancet Haematology.
Apr 11, 2024
0
29
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
Mar 29, 2024
0
1
Treatment for infants who have severe pulmonary arterial hypertension (PAH) is sometimes limited. Because they haven't physically matured, a procedure could increase the risk of serious complications, including failure of ...
Feb 22, 2024
0
0
University of Pittsburgh Schools of Medicine researchers uncovered a fundamental mechanism that controls the body's response to limited oxygen and regulates blood vessel disease of the lung.
Jan 10, 2024
0
19
Physicians should be aware of a potential serious adverse effect associated with sotatercept use. A case report detailing serious and recurrent gastrointestinal bleeding is published in Annals of Internal Medicine.
Jan 1, 2024
0
1
Exercise intolerance, or the inability to perform physical activity at the expected or desired level, is one of the many symptoms associated with long COVID. In a study, Yale researchers help explain what is explicitly driving ...
Dec 19, 2023
0
32
Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects ...
Dec 13, 2023
0
22
When women with diabetes become pregnant, they face not only the typical challenges of pregnancy and impending parenthood, but also a scary statistic: they're five times more likely to have a baby with a congenital heart ...
Nov 30, 2023
0
19
Through experiments on genetically modified mice, a team led by Ursula Quitterer, Professor of Molecular Pharmacology at ETH Zurich, determined which molecular switches are involved and how they need to be thrown to halt ...
Nov 22, 2023
0
30
Indiana University School of Medicine researchers at the school's South Bend regional campus, in collaboration with colleagues at the University of Notre Dame, have identified a new therapeutic target for pulmonary hypertension, ...
Nov 21, 2023
0
2
